Objective: Acute Myeloid Leukemia (AML) is one of the most common aggressive hematological malignancies. circDPY19L1P1 have been demonstrated to present upregulation in AML patients. We attempted to elucidate molecular…
Acute Myeloid Leukemia (AML) is an aggressive blood cancer that is usually fatal within weeks without effective therapy. Current treatment with standard chemotherapy agents fail to elicit complete clinical responses…
Acute Myeloid Leukemia (AML) is a clonal hematopoietic disorder characterized by an accumulation of immature leukemic cells and by a differentiation block. Despite recent progress, current treatment of AML remains…
Objectives: To evaluate and compare the levels of serum tryptase in patients of AML and CML before and after treatment and with controls. Methodology: The study included 25 newly diagnosed ... patients of AML and 20…
Perforin Despite major advances in recent years in elucidating the biology of AML, it remains a devastating disease. Approximately 12,000 new cases of AML are diagnosed ... each year, and two-thirds of young adults and…
Introduction: Acute myeloid leukemia (AML) is increasingly recognized as a heterogeneous group of disorders that shows considerable variation in behavior and outcome which, in a significant proportion of patients…
frequency and level of Ig gamma heavy chain (IgG) expression in acute myeloid leukemia (AML) and found that IgG was expressed at a high frequency and level in AML cell ... monocytes or neutrophils from patients with…
Acute myeloid leukemia (AML) is a heterogeneous group of disorders with regards to its pathology and molecular genetics features. Translocation (6;9)(p23;q34) is a cytogenetic aberration that ... found in specific…
minimal residual disease (MRD) causes relapse after chemotherapy in patients with acute myelogenous leukemia (AML) due to acquired drug resistance - this is induced by the attachment of the integrin receptor ... AS101…
most important roles for the classification and risk stratification of acute myeloid leukemia (AML). AML patients with a favorable risk cytogenetic profile are associated with relatively good responses to chemotherapy…
Background: Acute myeloid leukemia (AML) is a cytogenetically and molecularly heterogeneous diseases and characterization of transforming genetic events is becoming increasingly important. Interleukins (ILs) are a…
ATRA is a differentiation agent that revolutionized the treatment of a rare subtype of AML (APL, 5~10% of AML). However, it has not been useful for other subtypes ... AML. Here, we explore the effect of SALL4, a newly…
Effective treatment regimens for elderly FLT3/ITD+ AML patients represent a significant unmet need in the field. Recent data on the effects of the FLT3 tyrosine kinase inhibitor quizartinib ... FLT3/ITD+ AML showed…
Acute Myeloid Leukemia (AML) is a complex and aggressive form of blood cancer characterized by the rapid growth of abnormal white blood cells in the bone marrow. Despite significant advancements ... cancer research and…
Acute myeloid leukemia (AML) is associated with one of the top mortalities among all the hematologic neoplasms. Chemotherapy or radiotherapy alone, or with stem cell transplantation are current treatment strategies…
High risk myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML) are diseases of the aging; with many patients are unable to tolerate intensive therapies and an unmet need for novel ... therapeutic approaches…
studied immunoglobulin gamma heavy chain (IgG) expression in acute myeloid leukemia (AML) and found that IgG was expressed at a high frequency and level in AML cell lines and primary ... with non-hematopoietic neoplasms…
promoter of tumor suppressor always plays important roles in pediatric Acute Myeloid Leukemia (AML). CDH13 gene is a tumor suppressor involved in tumorigenesis, metastasis and apoptosis in a variety ... trying to…
Acute megakaryoblastic leukemia (AML-M7) is a rare type of acute myeloid leukemia (AML) evolving from primitive megakaryoblasts. It accounts for 1.2% of newly diagnosed AML by Eastern Cooperative Oncology ... grade…
Acute myeloid leukemia (AML) with mutated nucleophosmin 1 (NPM1mut) forms a particular entity in the WHO classification of AML (WHO classification 2017). Overall survival in patients with AML with NPM1mut ... possibly…
cancer. Aberrant DNA methylation is reported to have clinical significance in acute myeloid leukemia (AML) in adults; however, its impact on pediatric AML is relatively unknown. Our research focuses ... epigenetic…
including erythrophagocytosis, extramedullary disease, and poor prognosis with high relapse rate. These cases of AML are often categorized as M4, M5a, or M5b AML under the FAB system of AML ... classification. However…
influenced by pretreatment clinical features and prognosis of adults patients with acute myeloid leukemia (AML). Cytogenetic profiling separate AML patients into three broad prognostic groups: favorable, intermediate…
expression of CD90, 96, 117 and 123 among [CD34+/CD38-] cell population in AML patients at initial diagnosis. Results: It was found that percentage of CD90+ cells was lower among ... CD34+/CD38-] cells in of AML cases…
Haematological malignancies represent approximately 7% of all malignant diseases. Acute myeloid leukaemia (AML) is an aggressive and fatal disease. AML treatment basically remained unimproved in the last 20 years…
For authors and organisers
Publish, present and keep up with your field
Find the right journal for your paper and submit your manuscript.